How many institutions held SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in Q1 2014?

51 institutional investors reported SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share for Q1 2014. Use the holders table for investor-level position and value details.

SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

Q: What does CUSIP P8696W104 represent in this 13F holders report?

CUSIP P8696W104 is the security identifier for SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share used to aggregate holder disclosures.

CUSIP: P8696W104

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / Common Shares, par value US$0.001 per share
Shares outstanding: 71,872,133
Total 13F shares: 14,476,121
Share change: +1,855,826
Total reported value: $104,126,600
Put/Call ratio: 104%
Price per share: $7.20
Number of holders: 51
Value change: +$13,345,733
Number of buys: 31
Number of sells: 11

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2014
Previous quarter: Q4 2013

Recent filing periods for CUSIP P8696W104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	5.4%	3,888,473	$23,797,000	—	31 Dec 2013	13F
ORBIMED ADVISORS LLC	13F	Company	2.3%	1,637,500	$10,022,000	—	31 Dec 2013	13F
DAVIS SELECTED ADVISERS	13F	Company	1.6%	1,178,606	$7,213,000	—	31 Dec 2013	13F
FIL Ltd	13F	Company	1.5%	1,069,500	$6,545,000	—	31 Dec 2013	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.5%	1,054,996	$6,457,000	—	31 Dec 2013	13F
Visium Asset Management, LP	13F	Company	1.4%	1,000,000	$6,120,000	—	31 Dec 2013	13F
BlackRock Fund Advisors	13F	Company	0.88%	633,364	$3,876,000	—	31 Dec 2013	13F
Pine River Capital Management L.P.	13F	Company	0.69%	494,646	$3,028,000	—	31 Dec 2013	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.63%	453,900	$2,778,000	—	31 Dec 2013	13F
Invesco Ltd.	13F	Company	0.32%	229,748	$1,406,000	—	31 Dec 2013	13F
DEUTSCHE BANK AG\	13F	Company	0.26%	184,947	$1,130,000	—	31 Dec 2013	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.11%	75,900	$483,000	—	31 Dec 2013	13F
MORGAN STANLEY	13F	Company	0.09%	64,607	$396,000	—	31 Dec 2013	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.08%	60,518	$370,000	—	31 Dec 2013	13F
WEXFORD CAPITAL LP	13F	Company	0.08%	56,000	$343,000	—	31 Dec 2013	13F
HighTower Advisors, LLC	13F	Company	0.06%	43,650	$267,000	—	31 Dec 2013	13F
A.R.T. Advisors, LLC	13F	Company	0.05%	36,972	$226,000	—	31 Dec 2013	13F
TFS CAPITAL LLC	13F	Company	0.05%	34,458	$211,000	—	31 Dec 2013	13F
ELLINGTON MANAGEMENT GROUP LLC	13F	Company	0.05%	33,800	$207,000	—	31 Dec 2013	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.04%	27,623	$169,000	—	31 Dec 2013	13F
ProShare Advisors LLC	13F	Company	0.03%	24,134	$148,000	—	31 Dec 2013	13F
WESTPORT RESOURCES MANAGEMENT INC	13F	Company	0.03%	22,925	$140,000	—	31 Dec 2013	13F
Jane Street Holding, LLC	13F	Company	0.02%	17,000	$104,000	—	31 Dec 2013	13F
PDT Partners, LLC	13F	Company	0.02%	12,000	$73,000	—	31 Dec 2013	13F
CITADEL ADVISORS LLC	13F	Company	0.02%	11,020	$67,000	—	31 Dec 2013	13F
NAVELLIER & ASSOCIATES INC	13F	Company	0.01%	10,250	$63,000	—	31 Dec 2013	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	10,248	$62,000	—	31 Dec 2013	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.01%	7,755	$47,000	—	31 Dec 2013	13F
CITIGROUP INC	13F	Company	0.01%	7,517	$46,000	—	31 Dec 2013	13F
UBS AG	13F	Company	0.01%	7,382	$45,000	—	31 Dec 2013	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	3,800	$23,256	—	31 Dec 2013	13F
Creative Planning	13F	Company	0%	1,000	$6,000	—	31 Dec 2013	13F
MSI Financial Services Inc	13F	Company	0%	1,000	$6,000	—	31 Dec 2013	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	750	$5,000	—	31 Dec 2013	13F
GROUP ONE TRADING LLC	13F	Company	0%	734	$4,000	—	31 Dec 2013	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	596	$4,000	—	31 Dec 2013	13F
Apriem Advisors	13F	Company	0%	300	$2,000	—	31 Dec 2013	13F
WFG Advisors, LP	13F	Company	0%	200	$1,000	—	31 Dec 2013	13F
BARCLAYS PLC	13F	Company	0%	153	$1,000	—	31 Dec 2013	13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q1 2014

As of 31 Mar 2014, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 51 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,476,121 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, FIL Ltd, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, JANE STREET GROUP, LLC, and BOGLE INVESTMENT MANAGEMENT L P /DE/. This page lists 51 institutional shareholders reporting positions in this security for the Q1 2014 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2014 vs Q4 2013 Across Filers

Q4 2013 holders

Q1 2014 holders

Holder diff

Investor	Q4 2013 Shares	Q1 2014 Shares	Share Diff	Share Chg %	Q4 2013 Value $	Q1 2014 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.